Related Experiment Video
Updated: Mar 29, 2026
11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.5K
RRM1, ERCC1 and TS1 Immunofluorescence Expression in Leiomyosarcoma: A Tissue Microarray Study with Clinical Outcome
Sam D Zheng1, Katherine Bui1, Alberto Chiappori2
1Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
Pathology Oncology Research : POR
|November 28, 2015
Summary
High thymidylate synthase 1 (TS1) expression in leiomyosarcoma cytoplasm is linked to poorer survival. This finding may help predict leiomyosarcoma prognosis and guide future treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- ERCC1, RRM1, and TS1 are implicated in chemotherapy resistance in various cancers.
- Limited research exists on the correlation between these genes and clinical parameters in leiomyosarcomas.
Purpose of the Study:
- To investigate the expression patterns of ERCC1, RRM1, and TS1 in leiomyosarcoma.
- To determine the prognostic value of these genes in leiomyosarcoma by correlating their expression with clinical outcomes.
Main Methods:
- Utilized tissue microarray (TMA) and immunofluorescence with AQUA methods to quantify protein expression in 44 leiomyosarcoma samples.
- Analyzed expression levels and correlated them with overall survival.
Main Results:
- RRM1 and ERCC1 expression showed no significant correlation with overall survival.
- Cytoplasmic TS1 expression was significantly correlated with shorter overall survival (log-rank p=0.0498).
- This trend was validated using the Cox proportional hazards model.
Conclusions:
- Cytoplasmic TS1 expression is a potential prognostic marker for leiomyosarcoma.
- Targeting TS1 expression may offer a therapeutic strategy to improve overall survival in leiomyosarcoma patients.
- Further studies with larger sample sizes and detailed treatment information are needed for confirmation.
